Phase 1 is in human testing testing for safety and dosage and...

First 61 Last

Share
Profile

Follow
Hawk70

818 Posts.

239

10/05/24

14:54

Post #: 73766049
Share

Phase 1 is in human testing testing for safety and dosage and also if the drug is doing what it’s supposed to be doing on the brain.

Originally posted by Roch2077: ↑

Don’t take it from me, it’s all available 3 weeks ago in the investor conference

- phase 2 trials are next year and are in America and for both stroke and TBI together
- Phase 2 will look to take the grant from the US department of defence after Walter reed
- Phase 1 will do both Stroke and TBI on Australia
- drug will be fast tracked because of its indication and no drug put there does what it does

Hawk70 you’re trolling now and making things up again. Phase 1 is in human testing testing for safety and dosage and also if the drug is doing what it’s supposed to be doing on the brain.

This isn’t a 10 million market cap drug and on the upside it’s where AGN is which is a 100 million dollar drug. Answer my question why is AGN a 100 million market cap? Also why is phase 1 completed in Australia and phase 2 that starts next year in America? I thought you need FDA phase 1 and they can’t start phase 2 for years and years hahaha Your lying again Hawk70

https://youtu.be/Nbk__7w_6gw?si=5ZXBngbenfImg3pM

Expand

Your refusal to post links and refusal to read a document that is actually issued by the FDA tells everyone the validity of your statements.

I only hope that no-one was silly enough to follow your idiotic and easily provable untruths that you continue to post as fact.

I hope you buy, as you posted above, another $500,000 worth of shares.

Do it today, and I'm sure you will get exactly what you deserve out of it.

NYR Price at posting: 7.2¢ Sentiment: Sell Disclosure: Not Held
2 Upvote

0 Great analysis

Reply